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BRCA1, BRCA2, and Minireview
DNA Damage Response:
Collision or Collusion?
region encoded by exon 11 and another in the C-terminal
region of the protein. By contrast, BRCA1 colocalizes
with, but does not interact directly with hRAD51, sug-
gesting that they may be present within the same multi-
protein complex (Mizuta et al., 1997; Sharan et al., 1997;
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(Scully et al., 1997c). While the role of BRCA1 in DNA
damage response pathways remains speculative, a new
study by Patel et al. (1998) in the February issue of
Introduction Molecular Cell provides additional evidence of a role for
While the isolation of the breast cancer susceptibility BRCA2 in response to DNA damage, by examining the
genes BRCA1 and BRCA2 generated considerable me- phenotype of cells derived from mice homozygous for
dia and scientific interest, the nucleotide sequence of a truncated allele of BRCA2.
these genes did not yield much insight into their biologi- BRCA1, BRCA2, and RAD51
cal roles. Efforts to elucidate their function have been Several lines of evidence have led investigators to pos-
fraught with the difficulties inherent in working with large tulate a role for BRCA1 and BRCA2 in response to DNA
molecules that alter the growth characteristics of cells damage. These include: (1) colocalization of BRCA1,
and, in the case of BRCA1, significant controversy over BRCA2, and RAD51; (2) similarities in the chromosomal
data as fundamental as the subcellular compartmental- abnormalities seen following disruption of Rad51 and
ization of the protein. However, several recent reports BRCA2; and (3) the role of RAD51 in recombination, DNA
have provided insight into the cellular pathways that repair, and chromosome maintenance. Additionally, the
may be affected by alterations in BRCA1 and BRCA2 mammalian tissue expression pattern of Rad51 is very
(Connor et al., 1997; Scully et al., 1997a, 1997b, 1997c; similar to that of BRCA1 and BRCA2, with high-level
Sharan et al., 1997; Patel et al., 1998), and cellular re- expression primarily in testes and thymus, as might be
sponse to DNA damage is a consistent theme. expected of genes important in meiosis and recombina-
BRCA1 and BRCA2 Have Numerous Similarities tion, respectively (Friedberg et al., 1995; Rajan et al.,
BRCA1 and BRCA2 were localized to regions on chro- 1997).
mosome 17 and 13, respectively, using genetic linkage In order to understand how BRCA1 and BRCA2 might
in families with multiple breast and/or ovarian cancers. be acting in the response to DNAdamage, it is instructive
Mutations in these genes increase breast cancer risk to to firstexamine what isknown about RAD51 fromseveral
carriers by 15- to 20-fold over the general population species. hRAD51 catalyzes ATP-dependent DNA strand
risk. BRCA1 and BRCA2 behave as classic tumor sup- exchange reactions and is one of at least five human
pressor genes, in which loss of both alleles is required homologs of the prototypical E. coli recombination and
for the initiation of malignancy. Furthermore, they en- repair protein RecA. The yeast S. cerevisiae has a similar
code nuclear proteins with a cell-cycle regulated ex- set of RecA homologs that function in normal meiotic
pression pattern that colocalize in multiple tissues dur- and mitotic recombination, DNA damage repair, and
ing proliferation and differentiation (Rajan et al., 1997). chromosome segregation (Friedberg et al., 1995; Lim
BRCA1 and BRCA2 also both contain putative transcrip- and Hasty, 1996; and references therein). The homology
tional activation domains (Chapman and Verma, 1996; of RecA-related proteins is functional as well as struc-
Milner at al., 1997). Mice with targeted disruptions of tural, with the mouse Rad51 cDNA able to complement
the 59 end of BRCA1 or BRCA2 die early in embryonic the S. cerevisiae rad51 deletion mutant. However, the
development with evidence of reduced cellular prolifera- phenotypic effects of Rad51 deletion in different organ-
tion and increased expression of p21; these mouse em- isms highlights the difficulties inherent in cross-species
bryos survive several days longer in a p53- or p21-null comparisons. S. cerevisiae rad51 deletion mutants are
background (Ludwig et al., 1997, and references there- viable and exhibit sensitivity to UV- and g-irradiation as
in). Finally, no somatic mutations of either BRCA1 or well as monofunctional alkylating agents, with a defi-
BRCA2 have been identified in sporadic breast cancers. ciency in mitotic homologous recombination (which is
The first hint that BRCA1 and BRCA2 may be compo- required for double-strand break repair in yeast), and a
nents of DNA damage response pathways came from meiotic block that results in an inability to produce viable
their association with human RAD51 (hRAD51; Scully et spores. By contrast, deletion of Rad51 in mice is an
al., 1997a;Sharan et al.,1997; Wong, et al.,1997). BRCA2 early embryonic lethal defect, suggesting a role in prolif-
appears to interact directly with hRAD51, through at eration as well as recombination and repair (Lim and
least two binding sitesÐone in the N-terminal end of the Hasty, 1996). In fact, the inability to generate Rad512/2
ES cells suggests that RAD51 may be required for cell
viability in mammalian cells, an effect not seen in bacte-
ria or yeast.³To whom correspondence should be addressed.
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BRCA1ÐPotential Links to Other Proteins et al. is thenumerous spontaneous chromosomal abnor-
malities in the BRCA2Tr/Tr cells, with chromatid breaksThe reported association of BRCA1 with other proteins
also has led to speculation on BRCA1 and DNA repair. and the formation of triradials and quadriradials. These
abnormalities arise from defects in chromatid exchangeBRCA1 and hRAD51 have each been reported to be part
of a multiprotein complex that includes RNA polymerase during mitotic recombination, with triradials (Y-shaped,
three-armed chromosomes) reflecting ineffective sepa-II (Maldonado et al., 1996; Scully et al., 1997b). However,
while nucleotide excision repair can be coupled with ration after isochromatid exchange and quadriradials
(star-shaped four-armed chromosomes) being the resulttranscription, hRAD51 is not known to play a role in this
pathway, and thus the biological significance of these of aberrant exchange between chromosomes. These
chromosomal abnormalities are associated with in-data is unclear. Discussion also has arisen in the field
suggesting that BRCA1 may bind to hRAD50, which is creased levels of p53 and p21, which may explain the
proliferative defect of BRCA2Tr/Tr cells. Similar chromo-involved in both double-strand break (DSB) repair and
nonhomologous end joining. However, hRAD50 does somal abnormalities are observed in Rad51-null em-
bryos (Lim and Hasty, 1996), and are seen when RAD51-not colocalize with hRAD51 either in the absence of, or
following, DNA damage nor does it interact directly with deficient cells are passaged in culture (Sonada et al.,
1998). Coupled with the large number of abnormal chro-hRAD51 (Maser et al., 1997); thus, a clear connection
between hRAD50 and pathways involving hRAD51 and mosomes observed in BRCA2Tr/Tr cells, these results
suggest that BRCA2 and hRAD51 are involved in main-BRCA1 has not yet been made.
BRCA2 and DNA Damage Response taining appropriate chromosome segregation and/or
chromosomal repair. These chromosomal alterationsThe first direct indication that BRCA2 might be associ-
ated with the response to DNA damage was made by also are seen in cells derived from patients with Bloom
syndrome, a clinical syndrome in which genetic instabil-Sharan et al. (1997), who observed that disruption of
BRCA2 resulted in embryos that were hypersensitive to ity results in cancer predisposition. The genetic defects
in Bloom syndrome are mutations in BLM, which en-ionizing radiation, as observed in Rad51-null embryos
(Lim and Hasty, 1996). Additionally, disruptions of both codes a DNA helicase related to the E. coli RecQ heli-
case, a member of the RecF recombination pathwayBRCA2 and Rad51 result in arrest at a similar stage in
embryonic development. Finally, the expression pattern (Ellis et al., 1995). Bacterial recF mutants are deficient
in conjugational recombination and are UV sensitiveÐof BRCA2 and Rad51 in embryos is nearly identical,
and it has now been shown that BRCA2 and RAD51 striking similarities to the molecular defects seen in
Bloom syndrome and BRCA2Tr/Tr mice.physically interact with each other (Sharan et al., 1997;
Wong et al., 1997). Importantly, it is possible that the puzzling lack of
somatic BRCA1 and BRCA2 mutations in sporadicThe evidence implicating BRCA2 in DNA damage re-
sponse pathways has been considerably refined by breast cancers may be related to these severe chromo-
somal abnormalities. Conceivably, a developing cancerConnor et al. (1997) and Patel et al. (1998), using mice
with BRCA2 truncations that should produce a longer cell may only sustain a few subtle alterations at each cell
division that then provide a selective growth advantage,BRCA2 transcript than previously reported strains (mice
used by Patel et al., 1998, were generated as described while the gross chromosomal alterations, such as those
seen in the BRCA2Tr/Tr mice, are likely to be lethal. Asin Friedman et al., 1998). The lethality of more 59 disrup-
tions in BRCA1 and BRCA2 makes study of the pertinent has been suggested, perhaps a permissive event must
take place in breast and ovarian tumors that preventscellular pathways difficult, thus the generation of viable
mutant mice with truncated BRCA2 alleles has proven the deletion of cells with defective BRCA1 or BRCA2.
This has been proposed by Gusterson and colleaguesvery valuable (Connor et al., 1997; Friedman et al., 1998).
The generation of these mice revealed that BRCA2Tr/Tr (Crook et al., 1997) to be inactivation of p53, which is
consistent with this mechanism.mice are about one-third the size of their wild-type lit-
termates and have a shortened life span, and the mice Pathways that Respond to DNA Damage
BRCA1 and BRCA2 have been proposed to be involvedthat live to adulthood develop thymic lymphomas (a
phenotype similar to mice rendered null for other DNA in the response to DNA damage at several different
levels including: (1) cell cycle checkpoint activation, (2)damage response genes, including ATM). Cells derived
from BRCA2Tr/Tr mice have a proliferative defect, with induction of apoptosis, and (3) DNA repair. The tightly
linked cell cycle±dependent expression profile of BRCA1BRCA2Tr/Tr mouse embryonic fibroblasts (MEFs) exhib-
iting progressive growth retardation and markedly re- and BRCA2, with elevated levels at the G1/S transition
that remain elevated into G2 and then decline in earlyduced proliferative capacity in as few as three or four
passages. Of note, while all mice with BRCA2 disrup- G1 (Rajan et al., 1997), and the fact that BRCA1 is hyper-
phosphorylated in response to DNA damage (Scully ettions reported thus far retain the coding region for the
N-terminal putative transactivation domain and are de- al., 1997c), led to the hypothesis that one or both of
these genes may function incheckpoint activation. How-leted for the 39 region encoding the C-terminal Rad51
interaction domain, the BRCA2Tr alleles described by ever, one of the major points made by Patel et al. is that
BRCA2Tr/Tr MEF cells appear to have intact checkpointFriedman et al. and Connor et al. also retain the N-terminal
Rad51-binding domain encoded by exon 11. Unfortu- activation, as measured by a marked decrease in S
phase cells following exposure to either X- or UV-irradia-nately, lack of antibodies that recognize BRCA2 has so
far precluded determination of which, if any, of these tion and by abrogation of BrdU incorporation after treat-
ment with hydroxyurea. However, as noted by the au-proteins are expressed in the targeted cells.
One of the most significant findings describedby Patel thors, these cells are likely to be producing significant
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quantities of BRCA2Tr protein, which contains a putative in response to damaging agents. The other intriguing
finding described by Patel et al. is the spontaneoustransactivation domain in the amino terminus. This do-
main or other intact regions may be sufficient to confer occurrence of gross chromosomal abnormalities. This
observation suggests that there is a fundamental defectpotential checkpoint control functions in BRCA2Tr/Tr
cells. Patel et al. (1998) also suggest that induction of in chromosomal replication, repair, and/or segregation
in BRCA2Tr/Tr cells.apoptosis is intact in BRCA2Tr/Tr lymphoid cells, as mea-
sured by the ability of even very low levels of g-radiation The link between BRCA1 and BRCA2 and response
to DNA damage also leads to the exciting possibilityto induce apoptotic cell death.
With regard to DNA repair, BRCA2Tr/Tr MEF cells are that BRCA-related cancers may have differential sensi-
tivity tospecific chemotherapeutic agents and X-irradia-significantly more sensitive to UV irradiation and the
monofunctional alkylating agent methylmethanesulfo- tion, which in turn may influence clinical outcome. How-
ever, while recombination-mediated repair processesnate (MMS) than wild-type controls, a phenotype that
could be explained by a defect in nucleotide or base and controlof chromsomal segregation are obviouscan-
didates for further studies, the molecular mechanismsexcision repair (NER or BER). These authors indeed sug-
gest that BRCA2 may be associated with an excision by which BRCA2 exerts its influence on DNA repair re-
main largely unexplained. In this regard, there are arepair pathway. However, the UV-sensitive phenotype
of rad51 mutants is generally thought to be due to a number of cellular pathways involved in replication and
segregation that have yet to be evaluated, includingdefect in recombination-mediated repair. In addition,
both Connor et al. (1997) and Patel et al. (1998) describe spindle formation. Finally, while the work by Patel et
al. (1998) is a significant advance in understanding thesensitivity of BRCA2Tr/Tr mice to ionizing radiation, a phe-
notype more reminiscent of the rad51 yeast mutants function of BRCA2, this extremely large gene is likely
to have functions that touch multiple cellular pathways,than NER mutants, where little or no sensitivity to ioniz-
ing radiation is observed. These data, taken in context and it is quite plausible that other functions will be as-
cribed to BRCA1 and BRCA2 as our knowledge of thesewith all the direct and circumstantial evidence linking
BRCA2 and hRAD51, suggest that defects in recombina- proteins expands.
tion-mediated repair, as opposed to an excision repair
pathway, may be more relevant in relation to BRCA2.
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